Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Spero Therapeutics (SPRO) Debt Ratio (2016 - 2024)

Spero Therapeutics (SPRO) has disclosed Debt Ratio for 9 consecutive years, with 0.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Debt Ratio fell 83.39% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2024, down 83.39%, and an annual FY2023 reading of 0.0, down 37.99% over the prior year.
  • Debt Ratio was 0.0 for Q3 2024 at Spero Therapeutics, down from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.01 in Q1 2022 and bottomed at 0.0 in Q3 2024.
  • Average Debt Ratio over 5 years is 0.0, with a median of 0.0 recorded in 2021.
  • The sharpest move saw Debt Ratio surged 557.5% in 2022, then plummeted 90.19% in 2023.
  • Year by year, Debt Ratio stood at 0.0 in 2020, then crashed by 30.06% to 0.0 in 2021, then dropped by 4.64% to 0.0 in 2022, then crashed by 37.99% to 0.0 in 2023, then tumbled by 79.84% to 0.0 in 2024.
  • Business Quant data shows Debt Ratio for SPRO at 0.0 in Q3 2024, 0.0 in Q2 2024, and 0.0 in Q1 2024.